Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FX2FD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,500
Award facts
- Contract value 100% obligated
- $97,499.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded September 17, 2025, by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., provides for the supply of Stelara 90 mg/ml syringes with a firm fixed price ceiling value of $97,499.70 and an ultimate completion date of October 8, 2025. Stelara is a biologic immunosuppressant medication used to treat conditions such as psoriasis, rheumatoid arthritis, and Crohn's disease. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle through November 2026 that enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems. No set-aside designation was applied to this delivery order. The company has established itself as a key supplier within the federal pharmaceutical supply chain through its existing IDC with the DLA, which covers an extensive portfolio of medications and medical products across multiple categories including injections, tablets, and specialty pharmaceutical items for Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FX2FD?
SPE2DB25FX2FD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FX2FD worth?
The government has obligated $97,500 on SPE2DB25FX2FD.
Is contract SPE2DB25FX2FD an order under another contract?
Yes. SPE2DB25FX2FD is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2FD competed?
The extent of competition for SPE2DB25FX2FD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award